Business
Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan
These recent LungFit PH international agreements bring the ex-U.S. total to 34 countries and a combined population of 2.7 billion peopleGARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patient lives, today announced the expansion of its global LungFit® PH distribution network. The Company has recently
About this update from Beyond Air, Inc.
[{"type":"image","alt":"Beyond Air™","displaySize":"","headline":null,"caption":"Beyond Air™","className":"","disableSlideshowImg":false,"size":{"original":{"width":264,"height":50,"url":"https://media.zenfs.com/en/globenewswire.com/283e6374c7eeb2f53ca652917eb5334d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cVMIN3hdiWRLf4negBQkjw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/283e6374c7eeb2f53ca652917eb5334d","width":264,"height":50}},"lazy":false},{"type":"text","content":"These recent LungFit PH international agreements bring the ex-U.S. total to 34 countries and a combined population of 2.7 billion people","length":136,"tagName":"p"},{"type":"text","content":"GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patient lives, today announced the expansion of its global LungFit® PH distribution network. The Company has recently signed new distribution agreements in Japan, South Korea, Costa Rica, Guatemala, Panama, and El Salvador, bringing its total international coverage to 34 countries, representing a combined population of 2.7 billion people.","length":586,"tagName":"p"},{"type":"text","content":"The distribution partner in Japan is AMCO Incorporated, which, as a leading distributor of medical devices in the country, has been involved in successfully importing, marketing, and servicing medical and scientific products from the USA and Europe for over 70 years.","length":267,"tagName":"p"},{"type":"text","content":"“These latest agreements build upon the Company’s rapidly growing international footprint, which now spans the globe,” said Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. “With distribution agreements in place for 34 countries and counting, we are well-positioned to capture opportunities in both developed and emerging healthcare markets. Hospital tender submissions are already underway in several regions, while we await regulatory approval in others. These efforts are expected to drive significant adoption and have a lasting impact in the coming years.”","length":576,"tagName":"p"},{"type":"text","content":"Beyond Air’s LungFit PH generates nitric oxide from ambient ...